New Poll: 70% of Americans Support Medical Oversight for Abortion Pills
New polling data reveals most Americans agree there should be more oversight of the distribution and consumption of chemical abortion pills like mifepristone.
According to polling conducted by CRC Research for The 85 Fund, as reported by The Daily Wire and Susan B Anthony Pro-life America, approximately 70% of Americans support requiring an in person medical evaluation before and after taking the abortion pill.
A closely related question found that 67% of voters support requiring an in-person doctor’s visit in order to obtain the abortion pill. This policy was previously upheld by the FDA but abandoned by the previous pro-abortion administration.
Source: The Daily Wire
What makes this data so interesting and newsworthy is how it breaks down across political lines. Support for medical oversight was not limited to a single party. In fact, 72% of Republicans, 68% of Independents and 63% of Democrats all supported reinstating in-person doctor visits before accessing abortion pills.
The data shows a clear majority of Americans in every major political party support some form of in-person medical attention before abortion pills are dispensed.
Concerns over medical oversight are reinforced by research from the Ethics and Public Policy Center (EPPC), which raised questions about the safety of women using mifepristone last year.
As reported by the Daily Citizen in May, the EPPC released a study revealing nearly 11% of women who take the abortion pill experienced serious adverse effects within 40 days, including sepsis, hemorrhaging, infection and emergency room visits.
Those numbers are 22 times higher than the FDA’s current label, which suggests the rate of adverse effects is only 0.5%.
Following the release of the report, Senator Josh Hawley questioned HHS Secretary Kennedy at a committee hearing. The secretary committed to a complete review of the chemical abortion pill by the FDA.
Instead of cracking down on the abortion pill, the FDA has made abortion pills even more available by approving a generic abortion pill alternative.
Several pro-life organizations and advocates have accused HHS and the White House of intentionally slow-walking the review. They argue that recent findings demonstrate the need for stronger safeguards and removing in-person visits and medical oversight allows for serious complications to go untreated.
Susan B. Anthony Pro-Life America is calling on the Trump administration to revisit current FDA protocols and reinstate requirements that were previously in place, including in-person dispensing and physician oversight. They argue basic medical standards should apply to abortion.
Recently, Senator Josh Hawley recently introduced a senate bill to ban the abortion pill and give women the right to sue manufacturers for damages. Congresswoman Diana Harshbarger, a pharmacist, introduced companion legislation in the House of Representatives.
When abortion policy is often sharply divided, broad bipartisan support from a majority of Americans for medical oversight of the abortion pill should not be ignored. HHS and the FDA should use their authority to restore in-person medical oversight for abortion pill use.
